This site uses cookies to ensure the best viewing experience for our readers.
Read more about it Got It
Blood Testing Startup Sight Diagnostics Reveals Investors in $28 Million Round

Blood Testing Startup Sight Diagnostics Reveals Investors in $28 Million Round

The company announced the private issuance in December via shareholder Clal Biotechnology Industries

CTech | 14:18, 18.02.19
Blood testing startup S.D. Sight Diagnostics Ltd. has announced additional details regarding its $27.8 series C round, first announced in December via its shareholder Clal Biotechnology Industries Ltd. On Thursday, the company revealed the round was led by Longliv Ventures, a member of multinational health and beauty conglomerate the CK Hutchison Group. Existing investors OurCrowd, Go Capital, and New Alliance Capital also participated.

Sight stated it will use the funding for research and development.

Blood test (illustration). Photo: Shutterstock Blood test (illustration). Photo: Shutterstock Blood test (illustration). Photo: Shutterstock

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS

No Comments Add Comment Add Comment